Sanofi — supply status, manufacturers & alternatives

Sanofi

—

In supply · Australia

In supply · 🇦🇺 Australia · short in🇨🇦 CA

In supply in Australia

Reading today’s signals…

✓ Can I substitute?

In supply

no shortage substitution needed

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Registrations on file
Active ingredient (INN)	Sanofi
Therapeutic category	Auto-created by Health Canada — Recalls and Safety Alerts scraper
Controlled substance	No
Marketing-authorisation holders	Sanofi Winthrop Industrie

Patient information leaflet (PIL)	Not on file

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Substitution pathways 🇦🇺 Australia · TGA

—

No substitution instrument in force

Dispense per normal rules, or refer to the prescriber. No active SSSI/S19A instrument detected for this medicine.

Recalls official enforcement reports

🇨🇦

Sanofi

Drugs and health products · June 2021

Class Idetails ↗

🇨🇦

Sanofi

Drugs and health products · June 2021

Class Idetails ↗

🇨🇦

Sanofi Consumer Health Zantac Product

Drugs and health products · Oct 2019

Class Idetails ↗

🇨🇦

Sanofi recalls all lots of Allerject (0.15 mg/0.15 mL and 0.3 mg/0.3 mL strengths of epinephrine aut

Communications and Public Affairs Branch · Oct 2015

Class ?details ↗

🇨🇦

Sanofi Toronto Facility Update Regarding ImmuCyst

Communications and Public Affairs Branch · July 2012

Class ?details ↗

🇨🇦

Sanofi Pasteur recalls tuberculosis (BCG) vaccine

Communications and Public Affairs Branch · June 2012

Class ?details ↗

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders2 registrations · 1 MA holder

Product	Strength	Form	Market	MA holder	Status
Insulin aspart Sanofi	—	—	🌐 EU	Sanofi Winthrop Industrie	Active
Insulin lispro Sanofi	—	—	🌐 EU	Sanofi Winthrop Industrie	Active

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.